Resources | Library

340B opportunity: What stakeholder collaboration can accomplish in 2021

Some manufacturers see 340B as a risk — but it’s also an opportunity. In this presentation, Kalderos CEO Jeremy Docken outlines the benefits for manufacturers in meaningful collaboration with 340B covered entities, and how a rebate model can help expand patient access to innovative treatments.

 

Download webinar presentation